Posted in | News | Solar Energy | Green Energy

Etrion Links Last Site of Mito Utility-Scale Solar PV Project in Japan

Etrion Corporation, a solar independent power producer, today announced that the last site of the Mito solar project in Japan has been connected to the grid and will start recognizing revenues by the end of August 2015 following testing.

Mito is a 9.3 megawatt (“MW”) utility-scale solar photovoltaic (“PV”) power project including five sites in the Ibaraki Prefecture. The Mito project includes a total of 28.3 hectares and is expected to produce a total of approximately 10.5 million kWh of solar electricity per year. The solar project is owned 87% by Etrion and 13% by Hitachi High-Technologies Corporation (“Hitachi High-Tech”) (TOKYO: 8036), a subsidiary of Hitachi, Ltd.

The project was built by Hitachi High-Tech using Canadian Solar poly-crystalline PV modules, fixed-tilt technology and Hitachi inverters. The project company has entered into a long-term, fixed-price operation and maintenance agreement with Hitachi High-Tech. The Mito project company has also entered into a 20-year power purchase agreement (“PPA”) with Tokyo Electric Power Company (“TEPCO”) under which the project will receive ¥40 per kilowatt-hour (“kWh”) of electricity produced. Sumitomo Mitsui Trust Bank, Limited provided 80% of the financing for the project with an 18-year, non-recourse loan.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.